EuroTimes wins major magazine award

Magazines Ireland award for the Business To Business Magazine of the Year (over 5,000 circulation)

EuroTimes wins major magazine award

Colin Kerr

Published: Friday, December 2, 2016

miawards

EuroTimes has won the Magazines Ireland award for the Business To Business Magazine of the Year (over 5,000 circulation) for the second year in a row. The judges said the magazine demonstrated commercial credibility and integrity coupled with great ambition and growth. Announcing the winners at a ceremony in Dublin Castle on Thursday, December 1, Magazines Ireland CEO Grace Aungier said that the awards recognised and rewarded genuine excellence among the editors, designers, publishing teams and brands that are performing at the very top of their game. "Irish people love their magazines and the awards ceremony is a celebration of the best of Irish magazine media - both business to business and consumer titles across a whole range of platforms,” she said.

Latest Articles

ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Supplement: ESCRS Clinical Trends Series: Presbyopia

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.